Copyright Reports & Markets. All rights reserved.

Global Seasonal Influenza Vaccines Therapeutics Market Research Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Seasonal Influenza Vaccines Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Seasonal Influenza Vaccines Therapeutics
      • 1.2 Seasonal Influenza Vaccines Therapeutics Segment by Type
        • 1.2.1 Global Seasonal Influenza Vaccines Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Paediatrics
        • 1.2.3 Adolescence
        • 1.2.4 Adults
        • 1.2.5 Elderly
      • 1.3 Seasonal Influenza Vaccines Therapeutics Segment by Application
        • 1.3.1 Seasonal Influenza Vaccines Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Seasonal Influenza Vaccines Therapeutics Market by Region
        • 1.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size
        • 1.5.1 Global Seasonal Influenza Vaccines Therapeutics Revenue (2014-2025)
        • 1.5.2 Global Seasonal Influenza Vaccines Therapeutics Production (2014-2025)

      2 Global Seasonal Influenza Vaccines Therapeutics Market Competition by Manufacturers

      • 2.1 Global Seasonal Influenza Vaccines Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Seasonal Influenza Vaccines Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Seasonal Influenza Vaccines Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Seasonal Influenza Vaccines Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Seasonal Influenza Vaccines Therapeutics Market Concentration Rate
        • 2.5.2 Seasonal Influenza Vaccines Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Seasonal Influenza Vaccines Therapeutics Production Market Share by Regions

      • 3.1 Global Seasonal Influenza Vaccines Therapeutics Production Market Share by Regions
      • 3.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Seasonal Influenza Vaccines Therapeutics Production
        • 3.4.1 North America Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Seasonal Influenza Vaccines Therapeutics Production
        • 3.5.1 Europe Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Seasonal Influenza Vaccines Therapeutics Production (2014-2019)
        • 3.6.1 China Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Seasonal Influenza Vaccines Therapeutics Production (2014-2019)
        • 3.7.1 Japan Seasonal Influenza Vaccines Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Seasonal Influenza Vaccines Therapeutics Consumption by Regions

      • 4.1 Global Seasonal Influenza Vaccines Therapeutics Consumption by Regions
      • 4.2 North America Seasonal Influenza Vaccines Therapeutics Consumption (2014-2019)
      • 4.3 Europe Seasonal Influenza Vaccines Therapeutics Consumption (2014-2019)
      • 4.4 China Seasonal Influenza Vaccines Therapeutics Consumption (2014-2019)
      • 4.5 Japan Seasonal Influenza Vaccines Therapeutics Consumption (2014-2019)

      5 Global Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Seasonal Influenza Vaccines Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Seasonal Influenza Vaccines Therapeutics Price by Type (2014-2019)
      • 5.4 Global Seasonal Influenza Vaccines Therapeutics Production Growth by Type (2014-2019)

      6 Global Seasonal Influenza Vaccines Therapeutics Market Analysis by Applications

      • 6.1 Global Seasonal Influenza Vaccines Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Seasonal Influenza Vaccines Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Seasonal Influenza Vaccines Therapeutics Business

      • 7.1 GSK
        • 7.1.1 GSK Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.1.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.1.3 GSK Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Novartis
        • 7.2.1 Novartis Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.2.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 CSL
        • 7.3.1 CSL Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.3.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.3.3 CSL Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 MedImmune
        • 7.4.1 MedImmune Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.4.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Sanofi-Pasteur
        • 7.5.1 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.5.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Solvay
        • 7.6.1 Solvay Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.6.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sinovac Biotech
        • 7.7.1 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.7.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Hualun Biologicals
        • 7.8.1 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Production Sites and Area Served
        • 7.8.2 Seasonal Influenza Vaccines Therapeutics Product Introduction, Application and Specification
        • 7.8.3 Hualun Biologicals Seasonal Influenza Vaccines Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served

      8 Seasonal Influenza Vaccines Therapeutics Manufacturing Cost Analysis

      • 8.1 Seasonal Influenza Vaccines Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Seasonal Influenza Vaccines Therapeutics
      • 8.4 Seasonal Influenza Vaccines Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Seasonal Influenza Vaccines Therapeutics Distributors List
      • 9.3 Seasonal Influenza Vaccines Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Seasonal Influenza Vaccines Therapeutics Market Forecast

      • 11.1 Global Seasonal Influenza Vaccines Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Seasonal Influenza Vaccines Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Seasonal Influenza Vaccines Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Seasonal Influenza Vaccines Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Seasonal Influenza Vaccines Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Seasonal Influenza Vaccines Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Seasonal Influenza Vaccines Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Seasonal Influenza Vaccines Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Seasonal Influenza Vaccines Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Seasonal Influenza Vaccines Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Seasonal Influenza Vaccines Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Influenza vaccine typically known as flu shot and is used for protection against influenza virus. 

        The global Seasonal Influenza Vaccines Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Seasonal Influenza Vaccines Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Seasonal Influenza Vaccines Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        GSK
        Novartis
        CSL
        MedImmune
        Sanofi-Pasteur
        Solvay
        Sinovac Biotech
        Hualun Biologicals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Paediatrics
        Adolescence
        Adults
        Elderly

        Segment by Application
        Hospitals
        Clinics
        Others

        Buy now